Pancreatic Cancer Research

ResearcherShanghai Jiao Tong UniversityActive in the last 2 years

Xuebing Jia

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0000-9538-8594; OpenAlex author ID A5056495880. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2019: 2 papers · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper

Papers 3

  1. The Tautomerase Activity of Tumor Exosomal MIF Promotes Pancreatic Cancer Progression by Modulating MDSC Differentiation. Co-author DOI 10.1158/2326-6066.cir-23-0205↗
  2. FOXO1-regulated lncRNA LINC01197 inhibits pancreatic adenocarcinoma cell proliferation by restraining Wnt/β-catenin signaling. Co-author DOI 10.1186/s13046-019-1174-3↗
  3. MiR-27a-regulated FOXO1 promotes pancreatic ductal adenocarcinoma cell progression by enhancing Wnt/β-catenin signaling activity. Co-author PMID 31217876↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Weifeng Song · 2 shared papers, 2019 · strength 0.21
  2. Ling Jing · 2 shared papers, 2019 · strength 0.21
  3. Qi Li · 2 shared papers, 2019 · strength 0.21
  4. Qi Li · 1 shared paper, 2024 · strength 0.20
  5. Jiang Long · 1 shared paper, 2024 · strength 0.20
  6. Yuanyuan Zhang · 1 shared paper, 2024 · strength 0.20
  7. Lei Wang · 1 shared paper, 2019 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.